Xeris Biopharma vs. Billionaires
This is a news story, published by Yahoo Finance, that relates primarily to Xeris Biopharma Holdings Inc. news.
stocks trading & speculation news
For more stocks trading & speculation news, you can click here:
more stocks trading & speculation newsYahoo Finance news
For more news from Yahoo Finance, you can click here:
more news from Yahoo FinanceAbout the Otherweb
Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best business news, entertainment news, world news, and much more. If you like stocks trading & speculation news, you might also like this article about
other best multibagger penny stocks. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest Best Multibagger Penny Stocks news, popular stocks news, stocks trading & speculation news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
Penny StocksInsider Trading & Hedge Fund Data, and Investment Newsletter From Insider Monkey
•Business
Business & Economics
Is Xeris Biopharma Holdings Inc. (XERS) the Best Multibagger Penny Stock to Buy According to Billionaires?
79% Informative
Xeris Biopharma Holdings Inc. (NASDAQ:XERS) is a biopharmaceutical company that develops and commercializes innovative therapies across endocrinology, neurology, and gastroenterology segments.
The stock is up by 130.90% over the past year thanks to continued momentum in its commercial business.
The list is ranked based on the number of billionaires that hold stakes in them.
XERS ranks 4th on our list of best multibagger penny stocks to buy according to billionaires.
It’s already projecting a 30% revenue growth in 2025 of between $255 and $275 million .
XERS is projecting a substantial upside potential of XP8121 , a treatment for hypothyroidism.
VR Score
79
Informative language
79
Neutral language
18
Article tone
semi-formal
Language
English
Language complexity
56
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
long-living
External references
6
Source diversity
1
Affiliate links
no affiliate links
Small business owner?